Medicare utilization — MELISSA GISELL SALDIVAR (FNP-C)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | 5,235 | 12 | $0 | $157,384 |
| 95117 | Professional service for multiple injections of allergen | 549 | 50 | $0 | $3,548 |
| 96372 | Injection of drug or substance under skin or into muscle | 216 | 24 | $0 | $1,807 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 54 | 42 | $0 | $3,761 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 16 | 14 | $0 | $921 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·